Salvage of catabolic products in ganglioside metabolism: a study on rat cerebellar granule cells in culture  by Riboni, Laura et al.
FEBS Letters 391 (1996) 336-340 FEBS 17379 
Salvage of catabolic products in ganglioside metabolism: 
a study on rat cerebellar granule cells in culture 
Laura Riboni, Rosaria Bassi, Alessandro Prinetti, Guido Tettamanti* 
Study Center for the Functional Biochemistry ofBrain Lipids, Department ofMedical Chemistry and Biochemistry, The Medical School, 
University of Milan, via Saldini 50, 20133 Milan, Italy 
Received 20 June 1996 
Abstract Cerebellar granule cells in culture were subjected to a 
pulse (0.5--4 h)-chase (0-4 h) of 10 -6 M [3H]ganglioside GM1 
carrying the radioactive label at the level of NeuAc ([3H- 
NeuAc]GM1), Sph ([aH-Sph]GM1) or Gal ([aH-Gal]GM1) and 
the formed [~Hlmetabolites were determined. With aH forms of 
[3H]GM1, there was formation of [3H]catabolites, including 
[3H]H20 and [3H]biosynthetic products obtained by recycling of 
[3H]NeuAc, [3l-1]Sph and [3H]Gal released uring intralysosomal 
ganglioside degradation (salvage processes). Much higher 
amounts of [al-l]HzO were produced from [3H-Gal]GM1 than 
[3H-Sph]GM1 and [~I-NeuAc]GM1; conversely, more products 
from salvage processes (polysialogangliosides GDla, GDlb, 
GTIb, O-acetylated GTlb, protein-bound radioactivity) were 
obtained with [3H-NeuAcIGM1 than the two other forms of 
[3H]GM1. Liberated [3H]NeuAc produced 10-fold less tritiated 
water and 10-fold higher salvage products than [3H]GaI. Using 
[3H-NeuAc]GM1, granule cells appeared to metabolize 7.7% of 
membrane-incorporated xogenous GM1 per hour with a high 
degree of NeuAc recycling and the calculated metabolic half-life 
was 6.5 h. 
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1. Introduction 
Exogenously added gangliosides (1)are taken up by cells in 
culture, and are partly inserted into the outer plasma mem- 
brane layer, thus mimicking the major localization of cellular 
gangliosides [1,2]. A portion of incorporated gangliosides i
internalized by endocytosis [3] and then rapidly subjected to 
metabolic processing [1,4,5]. This behavior appears to be 
shared by normal, as well as tumoral, proliferating, and dif- 
ferentiating cells [1]. It is believed that exogenous gangliosides 
are endocytosed and metabolically processed following the 
routes of intracellular traffic and metabolism of endogenous 
gangliosides [3,6,7]. 
The metabolic events run by gangliosides after endocytosis 
were established [6,8-10] to be as follows: (a) a minor portion 
is directly sorted to the Golgi stacks or trans-Golgi network, 
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(i) Gangliosides are named according to Svennerholm [35]. 
Abbreviations." Sph, sphingosine; NeuAc, N-acetylneuraminic acid; 
Gal, galactose; HPTLC, high performance thin layer chromatography; 
FCS, fetal calf serum; BME, basal medium Eagle; EMEM, Eagle's 
minimum essential medium; DIC, days in culture 
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where gangliosides can undergo further glycosylations ('direct 
glycosylation'), and (b) a major portion reaches the lysosomal 
apparatus, where gangliosides are degraded. Intralysosomal 
degradation is the preeminent route of ganglioside catabolism, 
thus playing a primary role in their turnover. Available data 
on ganglioside turnover are extremely heterogeneous. After 
administering radioactive low molecular weight precursors 
to cells or animals, half-lives varying from hours to weeks 
were reported [4,11-18]. A possible xplanation for this varia- 
bility may reside in the failure to consider 'salvage processes', 
that is the re-use of some catabolic products for biosynthesis. 
In fact, different studies [5,13,19-23] indicate that some prod- 
ucts (sugars, sphingosine, fatty acid) are rapidly and actively 
recycled for biosynthetic purposes, Thus, the issue is raised 
whether and how much salvage processes contribute to the 
overall ganglioside turnover. 
The aim of the present study was to compare the extent of 
(a) intralysosomal breakdown, (b) salvage processes, and (c) 
formation of terminal catabolites, under conditions of gang- 
lioside metabolization following endocytosis. To this purpose, 
rat cerebellar granule cells in culture were subjected to a 
pulse-chase of exogenous ganglioside GM1, carrying a tritium 
label at the level of the sphingosine, sialic acid or terminal 
galactose moiety, and the fate of radioactivity followed. Also, 
comparative studies on sphingosine salvage were performed 
on cultured rat cerebellar astrocytes, human skin fibroblasts, 
HeLa cells and murine Neuro2a neuroblastoma cells, besides 
cerebellar granule cells. The results obtained support he no- 
tion that salvage processes, particularly for sialic acid and 
sphingosine, represent a major route of ganglioside metabo- 
lism, and should be carefully considered when calculating the 
metabolic half-life of gangliosides. 
2. Materials and methods 
2.1. Chemicals 
Culture media, poly-L-lysine, 1-0~-D-arabinofuranosylcytosine, 
NeuAc, Vibrio cholerae sialidase and crystalline bovine serum albumin 
were from Sigma (St. Louis, MO, USA); HPTLC plates from Merck 
(Darmstadt, Germany); NaB[3H]4 (6.5 Ci/mmol); (C[SH]zCOhO (8.1 
Ci/mmol) from Amersham International (Amersham, UK). 
2.2. Preparation of radiolabelled gangliosides 
Ganglioside GM1, obtained as previously described [24], was ~H- 
labeled (a) at the long chain base ([3H-Sph]GM1) [25], the molecular 
species containing erythro-C18 being separated by reverse phase 
HPLC [26], (b) at the terminal galactose ([3H-Gal]GM1) [27], and 
(c) at the sialic acid acetyl group ([aH-NeuAc]GM1) [28]. The radio- 
chemical purity was better than 99% for all labeled compounds and 
the specific radioactivity was 1.88, 1.05 and 4.05 Ci/mmol for [3H- 
Sph]GM1, [3H-Gal]GM1 and [SH-NeuAc]GM1, respectively. Stand- 
ard [3H]gangliosides, [SH]neutral glycolipids, [ZH]sphingomyelin, 
[3H]ceramide, and [SH]sphingosine w re obtained as previously re- 
ported [23]. 
All rights reserved. 
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2.3. Cell cultures and treatment of cells with [3H]gangliosides 
Primary cultures of granule cells and astrocytes were prepared from 
the cerebellum of 8-day-old rats and cultured as previously described 
[29-31]. Both cell types were plated on poly-L-lysine coated ishes and 
cultured in supplemented BME containing 10% FCS. Granule cells 
were used at the 8th DIC, when they were fully differentiated [29], and 
astrocytes at the 10-12th DIC, when type I ceils prevailed and neu- 
rons were absent [31]. Human fibroblasts were obtained from skin 
explants and grown according to Leroy et al. [32]; HeLa cells and 
murine Neuro2a neuroblastoma cells (CCL 131) were obtained from 
the American Cell Type Culture Collection (Bethesda, MD, USA). 
These cells were cultured in EMEM (HeLa cells and human skin 
fibroblasts) or DMEM (Neuro2a cells) containing 10% FCS and anti- 
biotics. All cells were incubated at 37°C in an atmosphere of 5% CO2 
and 95% air. Cell viability and morphology were inspected by phase- 
contrast microscopy. Treatment with radiolabeled gangliosides was 
carried out as follows: dishes were washed twice with temperature 
conditioned media without FCS and incubated (pulse) for a given 
period of time (from 30 min to 4 h) in the same medium (2 ml/60 
mm dish) containing 1 or 2× 10 -6 M [3H]GM1, and carrying 1 or 2 
IxCi/ml, respectively. Therefore, the three differently labelled forms of 
GM1 were diluted to the same specific radioactivity, 1 or 2 Ci/mmol. 
The medium was then removed and the cells washed (2 ml/dish, 10 
min treatment, hree times) with a medium containing 10% FCS. In 
the pulse-chase xperiments, cells were further incubated in 10% FCS 
medium for 4 h. At the end of the pulse or chase period, the medium 
was carefully collected and cells, rinsed twice with ice-cold phosphate- 
buffered solution, were scraped off the plates and lyophilized. The 
medium collected after the pulse or chase period was cleared by cen- 
trifugation, and subjected to (a) fractional distillation for tritiated 
water determination [21], (b) lipid extraction, or (c) lyophilization 
and dialysis for the determination of non-volatile low molecular 
weight (radioactive) products. Owing to the overwhelming preponder- 
ance of [3H]GM1 in the pulse medium [3H]water and low molecular 
weight [3H]metabolites released by cells into the medium could be 
accurately determined in the chase, but not the pulse, medium. 
2.4. Lipid extraction, purification and fractionation 
Total lipids were extracted and partitioned from cells and chase 
media, as previously described [23]. The individual [3H]lipids con- 
tained in the aqueous (gangliosides) and organic (non-ganglioside lip- 
ids) phases were separated by HPTLC and quantified (see below). 
The recognition and identification of individual all-labeled ganglio- 
sides, neutral glycolipids, sphingomyelin, ceramide, and sphingosine 
were achieved as previously reported [23]. The separation of different 
lipids (and sphingosine) was performed by one-dimensional HPTLC, 
using: (a) chloroform/methanol/0.2% aqueous CaC12 (50:42:11, by 
volume), or chloroforrrdmethanol/0.2% aqueous CAC12/32% NH4OH 
(60:50:9:1, by volume) or propanol/32% NH4OH/water (6:2:1, by 
volume), for gangliosides; (b) chloroform/methanol/water (55:20:3, 
by volume), or chloroform/methanol/32% NH4OH (40:10:1, by vol- 
ume) for non-ganglioside lipids and sphingosine. The radioactivity 
linked to each separated lipid was measured and the corresponding 
quantity (as pmol/mg protein) calculated. 
The pellet obtained after lipid extraction ('protein pellet') was sub- 
jected to radioactivity counting (protein-bound radioactivity). Release 
of radioactive NeuAc from the protein pellet was accomplished by 
Vibrio cholerae sialidase treatment, as described [22]. 
2.5. Colorimetric methods 
Gangliosides were determined as lipid-bound NeuAc, using NeuAc 
as the standard [33]. Total proteins were assayed [34] with bovine 
serum albumin as the standard. 
2.6. Determination of radioactivity 
Radioactivity was determined by liquid scintillation counting, fluor- 
ography or radiochromatoscanning (Digital Autoradiograph, Ber- 
thold, Germany) [23]. Determinations were made on at least three 
experiments in duplicate and the S.D. values were calculated. 
3. Results and discussion 
After a pulse with [3H]GM1 and a subsequent 30 min per- 
iod of washing with FCS, the amount of radioactivity asso- 
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Fig. 1. Incorporation of radioactivity into total organic metabolites 
after different pulse times with 1 gM [3H-NeuAc]GM1 (O), [3H- 
Sph]GM1 (zx), [3H-Gal]GM1 (11). The specific radioactivity was the 
same in the different forms of [3H]GM1. Data are the mean values 
of three experiments in duplicate. S.D. values never exceeded 12% 
of the mean values. Each of the formed [3H]metabolites (with the 
exclusion of [aH]H20) from administered [ZH]GM1 was separated, 
the bound radioactivity measured, and the corresponding amount of 
compound calculated and expressed as pmol/mg cell protein. Total 
organic metabolites i  the sum of these substances. 
ciated with cells (constituted mainly by the serum stable form 
of [3H]GM1 associated with the plasma membrane, plus 
formed non-volatile [3H]metabolites) was practically identical 
with the three different species of 3H-labeled GM1, and rap- 
idly increased with pulse time, from 55 + 6 pmol/mg protein 
at 30 min to 140+ 12 pmol/mg protein at 4 h. Remarkably, 
when each pulse treatment was followed by a 4 h chase, a 
substantial amount of radioactivity was released in the med- 
ium. This radioactivity was mainly constituted by [3H]GM1, 
which shifted from 47% of the total associated radioactivity at 
30 min pulse to a constant average of about 32% from 1 to 4 
h pulse. As a consequence of this bleeding, the membrane 
associated GM1 truly available to endocytosis and metabolic 
processing was calculated to be 30 + 3 and 95 + 8 pmol/mg 
protein at 30 min and 4 h pulse, respectively. In agreement 
with previous studies [5,7,22,23] in cerebellar granule cells the 
incorporation of [aH]GM1 was found to be accompanied by 
the rapid formation of radiolabelled metabolites. The time 
course of formation of total [3H]organic metabolites during 
pulse is shown in Fig. 1. With all the different forms of 
[3H]GM1 a linear relationship between the organic rnetabo- 
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Fig. 2. Incorporation of radioactivity into water and total organic 
metabolites after different pulse times with 1 ~tM [SH-NeuAc]GM1 
(e), [3H-Sph]GM1 (zx) and [3H-Gal]GM1 (11), followed by 4 h 
chase. Radioactive water recovered in the culture media during 4 h 
chase was measured. The same experimental conditions referred to 
in Fig. 1 were employed. All data are the mean values of three ex- 
periments, performed in duplicate. S.D. values never exceeded 15% 
of the mean values. 
lites formed and time was observed until 4 h of pulse. How- 
ever, the amount of [aH-NettAc] metabolites was higher than 
that of [3H-Sph] and [all-Gall ones, the latter exhibiting the 
lowest radioactivity values. Since the three forms of [3H]GM1 
are metabolized at the same rate and extent in granule cells, 
the formation of different amounts of total [3H]organic prod- 
ucts with the three forms of tritiated GM1 supports the no- 
tion that released radiolabeled NeuAc, Sph and Gal undergo 
a different metabolic fate. 
To test this hypothesis [all]organic metabolites and 
[SH]water, the terminal catabolite of released [aH]NeuAc, 
[SH]Sph and [SH]Gal, were determined in experiments where 
a pulse period of 0.5-4 h was followed by a chase of 4 h. The 
formation of [SH]water during chase increased with pulse time 
and was, quantitatively, dependent on the labeled portion of 
GM1 (Fig. 2). After 1 h pulse, followed by 4 h chase, it was 
only 0.7+0.1 pmol/mg protein with [3H-NeuAc]GM1, and 
raised to 3.0-+0.3 and 6.7-+0.9 pmol/mg protein with [aH- 
Sph]GM1 and [SH-Gal]GM1, respectively. Conversely, the to- 
tal amount of [SH]organic metabolites was much greater with 
[3H-NeuAc]GM1 than with the other labeled forms of GM1 
(after 1 h pulse and 4 h chase, 15.8 -+ 1.8 pmol/mg protein with 
[aH-NeuAc]GM1 vs. 13.0-+1.5 and 7.8-+0.9 with [3H- 
Sph]GM1 and [3H-Gal]GMI, respectively). Particularly, at 
the shortest pulse times, after 4 h chase, the sum of tritiated 
water and organic metabolites was similar for all forms of 
[3H]GMI(2). After 1 h pulse and 4 h chase, the percentage 
of the terminal catabolite to total metabolites was 46.2%, 
18.8% and 4.2% with [aH-Gal]GM1, [aH-Sph]GM1 and [aH- 
NeuAc]GM1, respectively. It should be remembered that with 
all the different forms of [aH]GM1, the formation of 
(2) At the longest pulse times, the sum of [all]water (assayed in the 
chase medium) and [3H]organie metabolites was different with the 
different forms of [aH]GM1, and lower with [aH-Gal]GM1 than 
[3H-NeuAc]GM1. This is presumably attributable to [aH]H20, liber- 
ated during pulse into the culture medium, in higher amounts with 
[SH-Gal]GM1 than [aH-NeuAc]GM1. As mentioned in Section 2, 
[3H]H20 could not be accurately assayed in the pulse medium. 
3 
£ 
13. 
~2 
E 
E 
1 
POLYS IALOGAN GL IOS ID ES  PROTEIN-BOUND 
4 4 
/ 
/ 
/ 3 
11 
/ 
/ 
! 
2 / 
// 
// 
/ . .A  j 
J z . 
r ' i ! , 0 ~- i 
1 2 3 4 0 1 
PULSE, hours 
/1 Ie 
i i  
i I 
i i  
i i  
I I 
2 3 4 
Fig. 3. Incorporation of radioactivity (as bound labeled NeuAc, Sph 
or Gal) into metabolites derived from salvage processes and com- 
mon to the three differently labeled GM1 species (polysialoganglio- 
sides and the delipidized protein pellet) after different pulse times 
with 1 ~tM [aH-NeuAc]GM1 (e), [3H-Sph]GM1 (zx) or [aH-Gal]- 
GM1 (111). The same experimental conditions referred to in Fig, 1 
were employed. All data are the mean values of three experiments 
in duplicate, S.D. values never exceeding 15% of the mean values. 
[all]water equires previous liberation of [SH]NeuAc, [aH]Sph 
and [aH]Gal from GM1, a process that takes place in the 
lysosomes and produces simultaneously equimolar amounts 
of [3H]NeuAc, [3H]Sph and [SH]Gal. Since the products of 
lysosomal degradation of GM1 are quantitatively the same 
and the total radiolabeled metabolites ([3H]H20 included) 
are also the same with the different forms of [aH]GM1, the 
less tritiated water is produced, the more label is metabolically 
recycled. In other words, liberated [3H]NeuAc, which pro- 
duces about 10-fold less tritiated water than [3H]Gal, is sub- 
jected to a 10-fold higher salvage process. It is worth noting 
that the time course of [aH]metabolite production from 
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Fig. 4. Formation of radioactive metabolites from degradative path- 
ways and salvage processes after different pulse times with 1 ~tM 
[aH-NeuAc]GM1 followed by 4 h chase. Products of degradation 
(O) were represented by GM2, GM3 and water; products of salvage 
processes (zx) were represented by polysialogangliosides and sialy- 
lated proteins. Radioactive metabolites were determined in the aqu- 
eous phase (gangliosides), culture medium (water) and delipidized 
cell pellet (sialo-proteins) as described in Section 2. All data are the 
mean values of three experiments in duplicate, the S.D. never ex- 
ceeding 15% of the mean values. 
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Fig. 5. Formation of [aH]sphingosine and [3H]sphingomyelin from [3H-Sph]GM1 in different cells in culture. Cells were exposed for 2 h to 
2 btM [aH-Sph]GM1, followed or not by 4 h chase. Data are the mean of three experiments performed in duplicate, S.D. never exceeding 15% 
of the mean values. 
[3H]GM1 is different in the pulse (Fig. 1) and chase (Fig. 2) 
experiments. In particular, the rate of production decreases 
with time in the second case, where no more [3H]GM1 can 
be taken up by cells from the culture medium. This apparent 
discrepancy can be explained considering that in the chase 
experiment he starting amount of 3H-labeled molecules 
(mainly [3H]GM1) is fixed and the tendency prevails with 
time to reach an equilibrium between degradation and salvage 
biosynthesis products, whereas in the pulse experiment more 
and more [3H]GM1 molecules are taken up and metabolized, 
and the formation of degradation products is prevalent over 
that of the biosynthetic products. 
Polysialogangliosides (mainly constituted by GDla, GDlb, 
O-Ac-GTlb and GTlb) represent he [3H]metabolites, ob- 
tained by salvage processes, that are common to the three 
forms of labeled GM1. As shown in Fig. 3, [3H]NeuAc, 
[3H]Sph and [aH]Gal are all reutilized for the biosynthesis 
of polysialogangliosides. However, at all pulse times, the for- 
mation of labeled polysialogangliosides was much greater with 
the [3H]NeuAc label than [aH]Sph and [all]Gal. [aH]NeuAc 
and [3H]Gal also served for the biosynthesis of the glycocon- 
jugates (of non-ganglioside nature) present in the 'protein pel- 
let'. Fig. 3 shows that much more [3H]NeuAc than [3H]Gal 
was incorporated, along with pulse time, in the protein pellet. 
It is noteworthy that, after [3H-NeuAc]GM1 pulse, protein- 
bound radioactivity completely disappeared upon exhaustive 
treatment with Vibrio cholerae sialidase, indicating that bound 
radioactivity was carried by recycled [3H]NeuAc released from 
[3H-NeuAc]GM 1. 
The time course of formation of total metabolites of cata- 
bolic origin (tritiated water, GM2 and GM3 (3)) and of biosyn- 
thetic, predominantly salvage, origin (polysialogangliosides 
and protein-bound [aH]NeuAc) upon administration of [3H- 
(3) Radioactive-free sialic acid, evaluated as dialysable non-volatile 
radioactivity after [3H-NeuAc]GM1 pulse, was present only in trace 
amounts. 
NeuAc]GM1 is presented in Fig. 4. During pulse up to 4 h, 
catabolic metabolites predominated over those from meta- 
bolic salvage, especially in the first 2 h. Instead, when a 4 h 
chase followed the period of pulse, the two groups of meta- 
bolites had closer contents, with the catabolic one being more 
represented up to 2 h pulse-4 h chase, whereas after 4 h pulse- 
4 h chase, the products from salvage processes tended to over- 
come those from degradation, indicating the persistence of 
[3H-NeuAc] as a precursor for metabolic re-cycling. 
After [3H-Sph]GM1 administration, besides polysialogan- 
gliosides, the following [3H]organic metabolites could be de- 
tected: GM3, GM2, lac-ceramide, glc-ceramide, ceramide, 
sphingosine and sphingomyelin. Among them, sphingosine 
could be derived solely from degradation and sphingomyelin 
from salvage processes. Therefore, the concomitant determi- 
nation of these two compounds gives a direct indication of the 
cell capacity to recycle [3H]Sph, liberated by catabolism of 
exogenous [3H-Sph]GM1, to produce [3H]sphingomyelin. 
This capacity was evaluated in different cells in culture: rat 
cerebellar granule cells, rat cerebellar astrocytes, human skin 
fibroblasts, Neuro2a neuroblastoma cells and HeLa cells. All 
cells were incubated with 2)< 10 -6 M labeled GM1, for 2 h 
and then subjected to chase for an additional 4 h. In all cases 
(Fig. 5) free [3H]Sph was produced with formation of 
[aH]sphingomyelin, and chase caused relatively small changes 
in [aH]Sph content, but a several-fold increase of 
[3H]sphingomyelin formation. Cerebellar astrocytes were by 
far the most active cells in recycling Sph to sphingomyelin, 
followed by HeLa cells and granule cells, Neuro2a cells ap- 
pearing the least active. During chase, the behavior of 
[3H]ceramide, which derives from both degradation and recy- 
cling processes, was different in the different cells. In Neuro2a 
and cerebellar granule cells its content underwent a several- 
fold increase (from 0.78 to 2.19 pmol/mg protein, and from 
2.46 to 10.31 pmol/mg protein, respectively), similar to sphin- 
gomyelin, whereas it decreased in astrocytes, fibroblasts and 
HeLa cells (from 3.52 to 2.23, 3.35 to 2.40, and 2.16 to 1.32 
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pmol/mg protein, respectively). All this indicates that salvage 
processes for Sph are active in all cell types, but at a quite 
different extent, presumably reflecting the pattern and meta- 
bolic turnover of the individual sphingolipids characteristic of
each cell. 
As a whole, the data presented in this paper show that 
when endocytosis operating along with membrane renewal, 
or in response to external stimuli, membrane bound ganglio- 
sides are subjected to intralysosomal degradation with forma- 
tion of metabolites that can be recycled for biosynthetic pur- 
poses. Interestingly, these salvage processes are more active 
for the ganglioside components, like NeuAc and Sph, the 
biosynthesis of which is more demanding from the energetic 
point of view. Remarkably, salvage processes for NeuAc con- 
stitute a metabolic flux that at a time after administration of
exogenous ganglioside allowing temporal coordination be- 
tween degradative and biosynthetic pathways is comparable 
to, or of the order of magnitude of, that of lysosomal degra- 
dation. Under these conditions, salvage processes greatly con- 
tribute to ganglioside renewal, thus becoming relevant in over- 
all ganglioside metabolism. After pulse with [3H- 
NeuAc]GM1, granule cells appeared to metabolize 7.7% of 
the membrane incorporated GM1 per hour. From these 
data, ganglioside half-life (calculated of course for the exogen- 
ously administered gangliosides) in cultured granule cells was 
about 6.5 h. According to literature data, the metabolic half- 
life of gangliosides, calculated after administration of radio- 
active low molecular weight precursors to cultured cells, 
ranges from 2-5 h in rapidly duplicating CHO cells to 30 h 
in some neurotumoral cells [4,14-18]. This wide range may 
well be due to the different cells and experimental pproaches 
employed. However, it is tempting to point out that mouse 
neuroblastoma cells, although of different origin (NB4IA and 
N18), provided apparent half-lives for ganglioside turnover of 
10 h with [3H]Gal [16] and 30 h with [aH]N-acetylmannosa- 
mine [17] as precursors. Our data may solve this seeming 
contradiction. In fact, [3H]Gal is subjected more to complete 
degradation and less to recycling, thus undergoing a more 
rapid decay in the ganglioside molecule: hence a lower appar- 
ent half-life. Conversely, [3H]NeuAc formed from [3H]N-acet- 
ylmannosamine is much less degraded and more recycled, thus 
exhibiting a slower decay and, by consequence, providing a 
higher (but unrealistic) value of half-life. Presumably, the half- 
lives of gangliosides, reported in the literature and calculated 
ignoring the occurrence of recycling of the labeled component 
of the ganglioside molecule, are excessive. Owing to the rap- 
idity and the efficiency of the salvage processes, much lower 
values for the rate of ganglioside turnover would be closer to 
the real ones. 
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